A detailed history of Nebula Research & Development LLC transactions in Cabot Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 22,201 shares of CBT stock, worth $1.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
22,201
Previous 17,134 29.57%
Holding current value
$1.7 Million
Previous $1.56 Billion 17.98%
% of portfolio
0.17%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$81.12 - $92.51 $411,035 - $468,748
5,067 Added 29.57%
22,201 $1.85 Billion
Q4 2024

Feb 14, 2025

BUY
$90.64 - $117.0 $713,427 - $920,907
7,871 Added 84.97%
17,134 $1.56 Billion
Q3 2024

Nov 14, 2024

SELL
$86.96 - $111.73 $603,502 - $775,406
-6,940 Reduced 42.83%
9,263 $1.04 Billion
Q2 2024

Aug 14, 2024

BUY
$90.69 - $102.77 $1.47 Million - $1.67 Million
16,203 New
16,203 $1.49 Billion

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $4.31B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.